{{Rsnum
|rsid=9369717
|Chromosome=6
|Orientation=plus
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene=CD2AP
|position=47586732
|Gene_s=CD2AP
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 4.6 | 46.2 | 49.2
| HCB | 2.2 | 15.6 | 82.2
| JPT | 4.4 | 22.2 | 73.3
| YRI | 0.0 | 27.0 | 73.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 2.2 | 15.6 | 82.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23681557
|Title=CD2AP is associated with end-stage renal disease in patients with type 1 diabetes
}}

{{on chip | FTDNA}}